The increase in the price target for Madrigal Pharmaceuticals by a reputable analyst firm like HC Wainwright & Co. signals a strong vote of confidence in the company's future prospects. This is likely to positively influence investor sentiment and could lead to a short-term increase in the stock price, given the significant jump in the target price and the maintenance of a Buy rating.